Enjoy complimentary customisation on priority with our Enterprise License!
The global bovine mastitis treatment system market size is estimated to grow by USD 551.33 million at a CAGR of 5.34% between 2023 and 2028.
The market is expanding due to heightened concerns about food safety. Mastitis affects milk quality and poses risks to consumer health. Dairy farmers invest in treatment systems to detect and address mastitis promptly, ensuring high-quality milk production. Meeting consumer demands for safe dairy products drives the adoption of these systems, enhancing consumer confidence and market competitiveness. Therefore, a growing emphasis on food safety and quality is expected to drive the growth of the global bovine mastitis treatment system market during the forecast period.
The market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Our market growth analysis report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the antibiotics segment will be significant during the forecast period. In the market, antibiotics are essential components in combating mastitis infections and restoring the health of dairy cattle. Several prominent pharmaceutical companies offer a diverse array of antibiotic products tailored specifically for mastitis treatment. Zoetis Inc., a leading animal health company, provides a range of antibiotic treatments, such as ceftiofur, which is a broad-spectrum cephalosporin effective against a variety of mastitis-causing bacteria.
Get a glance at the market contribution of various segments Download PDF Sample
The antibiotics segment was valued at USD 1,292.82 million in 2018. Boehringer Ingelheim International GmbH, another major player in the industry, offers a portfolio of antibiotics, including penicillin-based drugs and cephalosporins formulated to target mastitis pathogens. These companies leverage their extensive research and development capabilities, along with robust distribution networks, to ensure that dairy farmers have access to effective antibiotic solutions for addressing mastitis infections promptly and effectively. These factors will drive the growth of the antibiotics segment of the treatment system market during the forecast period.
The intramammary route of administration for treatment is a widely used method that involves the direct infusion of therapeutic agents into the udder through the teat canal. This targeted approach allows for the delivery of medication directly to the site of infection, maximizing efficacy while minimizing systemic side effects. Market players offer a range of intramammary treatment products designed to combat mastitis infections effectively. Further, as the demand for efficient and sustainable mastitis treatment solutions continues to increase, vendors are expected to innovate and expand their intramammary product offerings to meet the evolving needs of the dairy industry. This, in turn, will drive the growth of the intramammary segment of the market during the forecast period.
The systemic route of administration for bovine mastitis treatment involves the delivery of therapeutic agents through the bloodstream to target mastitis infections throughout the cow body. While less targeted than intramammary administration, systemic treatments are effective in treating both clinical and systemic mastitis cases. Market players offer a variety of systemic treatment options to address mastitis infections in dairy cattle. Furthermore, as the demand for efficient and sustainable mastitis treatment solutions continues to grow, vendors are expected to innovate and expand their systemic product offerings to meet the evolving needs of the dairy industry. This, in turn, will drive the growth of the systemic segment of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In North America, the market is well-established, supported by a robust dairy industry and advanced veterinary infrastructure. Market players include multinational pharmaceutical companies, specialized biotechnology firms, and veterinary equipment manufacturers. Pharmaceutical companies are key players in the North American market, supplying antibiotics and other medications essential for mastitis treatment.
Furthermore, dairy farmers and veterinary practitioners in North America rely on vendors operating in the market for access to high-quality products and expert guidance in mastitis prevention and treatment. Through ongoing research, innovation, and lack of knowledge exchange, market players and local partners can continue to advance mastitis control efforts, contributing to the sustainability and profitability of the dairy industry in North America. Hence, such factors are expected to drive market growth in this region during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Bio-Vet: The company offers bovine treatment systems such as Bovine CPR which can be mixed with dry feed, milk, or milk replacer.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
Integration of PLF technologies is the key factor driving market growth. PLF encompasses the use of advanced sensors, data analytics, and automation to monitor and manage individual animals health and welfare in real time. In the context of bovine mastitis PLF technologies enable dairy farmers to implement more targeted and proactive management strategies, resulting in improved detection, treatment, and prevention of mastitis infections. Furthermore, PLF technologies enable data-driven decision-making and proactive management practices. By integrating data from various sources, including milk quality tests, cow health records, and environmental sensors, PLF systems provide actionable insights and recommendations for mastitis prevention and treatment.
Furthermore, market players like Zoetis Inc. are leveraging PLF technologies to enhance their mastitis treatment systems and provide more personalized and targeted solutions. Additionally, by combining real-time monitoring, advanced analytics, and automated decision-making, these integrated solutions empower dairy farmers to detect mastitis cases earlier, implement targeted interventions more effectively, and optimize udder health outcomes across the herd. Thus, due to such factors, the market is expected to experience significant growth and innovation during the forecast period.
The emergence and adoption of automated detection systems and precision medicine is one of the primary market trends shaping growth. Technological advances utilize advanced sensors and algorithms to continuously monitor cow behavior, milk production, and udder health parameters in real time. By analyzing subtle changes in cow behavior and milk quality, these systems can detect early signs of mastitis, allowing farmers to intervene promptly and prevent the spread of infection within the herd.
Furthermore, advancements in treatment modalities and delivery systems are driving market growth by offering innovative solutions for mastitis management. These novel approaches enhance treatment efficacy, minimize the use of antibiotics, and reduce the risk of antimicrobial resistance, addressing sustainability concerns and regulatory pressures faced by the dairy industry. Therefore, rising technological advancements are expected to drive market growth during the forecast period.
Lack of awareness about the importance of proactive mastitis management practices among dairy farmers is a challenge that affects market growth. Many farmers, especially in developing regions, may not fully understand the preventive measures and treatment options available to combat mastitis effectively. Without adequate awareness and education, farmers may overlook early signs of mastitis or fail to implement proper hygiene protocols and preventative measures on their farms. This can lead to increased incidence of mastitis cases, reduced milk production, and higher veterinary costs, ultimately impacting the profitability and sustainability of dairy operations.
Additionally, farmers may continue to rely on traditional treatment methods, such as blanket antibiotic therapy, which can contribute to antimicrobial resistance and compromise the effectiveness of mastitis treatment over time. Therefore, the lack of awareness and education among dairy farmers regarding the importance of proactive mastitis management practices is expected to hinder the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market encompasses innovative solutions for addressing mastitis in dairy cows. This condition, affecting the Mammary glands, can lead to decreased milk production and increased use of antibiotic resistance. New products in this market include the use of ice cubes on teats to alleviate inflammation and the application of phenol for teat disinfection. Large companies, such as Boehringer Ingelheim International GmbH, are investing in the development of lockout products to prevent contamination and strengthen the immune system of dairy cows. Strategic mergers between industry players aim to create synergistic effects, enhancing the end products of dairy farming and ensuring the health and productivity of dairy herds.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
Bovine Mastitis Treatment System Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.34% |
Market Growth 2024-2028 |
USD 551.33 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.5 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Germany, France, India, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., HIPRA S A, Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market Forecasting ,Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.